Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what stocks of (a) meropenem, (b) doxycycline, (c) fentanyl, (d) morphine, (e) midazolam, (f) levomepromazine, (g) paracetamol, (h) ibuprofen, (i) salbutamol inhaler doses and (j) amoxicillin were held in (a) the Essential Medicines Buffer Stock or (b) the UK Stockpile of Medicines for Covid-19 Preparedness, as of 1 October 2021.
The following table shows the stocks of products in the Essential Medicines Buffer Stock (EMBS) and the United Kingdom Stockpile of Medicines for COVID-19 Preparedness in England as of 1 October. Data for the stocks held by the devolved administrations for the UK Stockpile of Medicines is not held.
| EMBS | COVID-19 Stockpile |
Meropenem | 94,398 vials | 382,130 vials |
Doxycycline | 0 | 816,184 capsules |
Fentanyl (vials) | 0 | 2,337,687 vials |
Morphine injectables | 0 | 364,646 vials |
Morphine tablets | 0 | 25,015 tablets |
Morphine oral solution | 100,739 bottles | 0 |
Midazolam | 0 | 5,563,570 ampoules/vials |
Levomepromazine | 0 | 776,600 ampoules |
Paracetamol infusion | 0 | 1,321,453 bottles |
Paracetamol | 0 | 3,351,232 tablets |
Ibuprofen | 0 | 0 |
Salbutamol inhaler | 0 | 0 |
Amoxicillin | 0 | 0 |